Associate Professor, Medicine, University of Wisconsin School of Medicine and Public Health
Hematology
Dr. Peiman Hematti, MD
|
|
Give Review
Peiman Hematti is an expert in the field of Hematology. He researched medicine at Tehran University of Medical Sciences School of Medicine. Doctor Peiman Hematti, MD is a published MD. He has 61 papers published. The most current publication "Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion." Dr. Peiman Hematti is registered with Medicare.
Publications
- Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes.
- MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis.
- A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
- Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates.
- Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.
- Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.
- Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blin...
- Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple Myeloma treated with borte...
- Biomaterial-mesenchymal stem cell constructs for immunomodulation in composite tissue engineering.
- Mesenchymal stem cell therapies: the quest for fine-tuning.
- TPL2 kinase regulates the inflammatory milieu of the Myeloma niche.
- Comparison of Breast and Abdominal Adipose Tissue Mesenchymal Stromal/Stem Cells in Support of Proliferation of Breast Cancer Cells.
- Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue.
- No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model.
- Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease.
- Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds.
- Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.
- In vitro characterization of macrophage interaction with mesenchymal stromal cell - hyaluronan hydrogel constructs.
- Macrophages in multiple Myeloma: emerging concepts and therapeutic implications.
- MAP3K8 kinase regulates Myeloma growth by cell-autonomous and non-autonomous mechanisms involving Myeloma-associated monocytes/macrophages.
- Potential role of mesenchymal stromal cells in pancreatic islet transplantation.
- Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype.
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple Myeloma cells.
- Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?
- Human embryonic stem cell-derived mesenchymal stromal cells.
- The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages.
- Clinical applications of mesenchymal stem cells in soft tissue augmentation.
- Clinical operational tolerance after renal transplantation: current status and future challenges.
- Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro.
- Human embryonic stem cell-derived mesenchymal progenitors: an overview.
- Graft-versus-host Disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes.
- Bone marrow stromal cells from multiple Myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in Myeloma cells.
- Characterization of mesenchymal stem cells from human vocal fold fibroblasts.
- Mesenchymal stem cell therapy for nonhealing cutaneous wounds.
- Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction.
- Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.
- Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells.
- Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.
- Mesenchymal stem cells in hematopoietic stem cell transplantation.
- Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-t...
- Role of mesenchymal stromal cells in solid organ transplantation.
- Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
- Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells.
- AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
- Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair.
- Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.
- Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
- Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blo...
- Modeling human hematopoietic stem cell gene therapy in nonhuman primates.
- The impact of low-dose busulfan on clonal dynamics in nonhuman primates.
- Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leuk...
- Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system.
- Effect of Chronic cytokine therapy on clonal dynamics in nonhuman primates.
- Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.
- Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
- Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model.
- Presumed choroidal and orbital mastocytosis.
- Cardiopulmonary and histological characterization of an Acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion.
Schools
Tehran University Of Medical Sciences Faculty Of Medicine
Cleveland Clin Found
National Institutes Of Health Clinical Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Cleveland Clinic Foundation -
Tehran University of Medical Sciences School of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics
Drug Facts
| NPI NUMBER | 1710953732 | |
| NPPES Provider LastName | HEMATTI | |
| NPPES Provider FirstName | PEIMAN | |
| NPPES Provider ZIPCode | 53792 | |
| NPPES Provider State | WI | |
| Specialty Description | Hematology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710953732 |
| Last Name Of The Provider | HEMATTI |
| First Name Of The Provider | PEIMAN |
| View All |
Similar Doctors
|
|
Dr. Shannon E. O'Mahar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce G. Baranski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel J. Cook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justine Y. Bruce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad S. Kahl, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tabraiz Mohammed, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kae I. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linh Khuu, MD
This Doctor is OpenDoctor Recommended.
|